{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "19059883", "DateCompleted": {"Year": "2009", "Month": "06", "Day": "25"}, "DateRevised": {"Year": "2023", "Month": "08", "Day": "07"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1165/rcmb.2008-0381OC"], "ArticleDate": [{"Year": "2008", "Month": "12", "Day": "04"}], "Journal": {"ISSN": "1535-4989", "JournalIssue": {"Volume": "41", "Issue": "1", "PubDate": {"Year": "2009", "Month": "Jul"}}, "Title": "American journal of respiratory cell and molecular biology", "ISOAbbreviation": "Am J Respir Cell Mol Biol"}, "ArticleTitle": "NAD(P)H quinone oxidoreductase 1 is essential for ozone-induced oxidative stress in mice and humans.", "Pagination": {"StartPage": "107", "EndPage": "113", "MedlinePgn": "107-13"}, "Abstract": {"AbstractText": ["One host susceptibility factor for ozone identified in epidemiologic studies is NAD(P)H quinone oxidoreductase 1 (NQO1). We hypothesized that after ozone exposure, NQO1 is required to increase 8-isoprostane (also known as F(2)-isoprostane) production, a recognized marker of ozone-induced oxidative stress, and to enhance airway inflammation and hyperresponsiveness. In this report, we demonstrate that in contrast to wild-type mice, NQO1-null mice are resistant to ozone and have blunted responses, including decreased production of F(2)-isoprostane and keratinocyte chemokine, decreased airway inflammation, and diminished airway hyperresponsiveness. Importantly, these results in mice correlate with in vitro findings in humans. In primary human airway epithelial cells, inhibition of NQO1 by dicumarol blocks ozone-induced F(2)-isoprostane production and IL-8 gene expression. Together, these results demonstrate that NQO1 modulates cellular redox status and influences the biologic and physiologic effects of ozone."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Pediatric Pulmonary Medicine, Department of Pediatrics, Duke University Medical Center, Box 2994, Durham, NC 27710, USA. voyno001@mc.duke.edu"}], "Identifier": [], "LastName": "Voynow", "ForeName": "Judith A", "Initials": "JA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Fischer", "ForeName": "Bernard M", "Initials": "BM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zheng", "ForeName": "Shuo", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Potts", "ForeName": "Erin N", "Initials": "EN"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Grover", "ForeName": "Amy R", "Initials": "AR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jaiswal", "ForeName": "Anil K", "Initials": "AK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ghio", "ForeName": "Andrew J", "Initials": "AJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Foster", "ForeName": "W Michael", "Initials": "WM"}], "GrantList": [{"GrantID": "HL081763", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "HL082504", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "ES07943", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "ES012496", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "ES011961", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01 ES016836", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am J Respir Cell Mol Biol", "NlmUniqueID": "8917225", "ISSNLinking": "1044-1549"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "CXCL8 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Chemokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-8"}, {"RegistryNumber": "0", "NameOfSubstance": "Oxidants"}, {"RegistryNumber": "147037-79-4", "NameOfSubstance": "keratinocyte-derived chemokines"}, {"RegistryNumber": "27415-26-5", "NameOfSubstance": "8-epi-prostaglandin F2alpha"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "7QID3E7BG7", "NameOfSubstance": "Dicumarol"}, {"RegistryNumber": "B7IN85G1HY", "NameOfSubstance": "Dinoprost"}, {"RegistryNumber": "EC 1.6.5.2", "NameOfSubstance": "NAD(P)H Dehydrogenase (Quinone)"}, {"RegistryNumber": "EC 1.6.5.2", "NameOfSubstance": "Nqo1 protein, mouse"}, {"RegistryNumber": "EC 1.6.99.1", "NameOfSubstance": "NADPH Dehydrogenase"}], "CommentsCorrectionsList": [{"RefSource": "Am J Respir Cell Mol Biol. 2016 Dec;55(6):909. doi: 10.1165/rcmb.556erratum", "PMID": "27906558"}, {"RefSource": "Fed Regist. 2019 Nov 7;84(216):60097-60098.", "PMID": "37547121"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects", "enzymology", "physiopathology"], "DescriptorName": "Bronchi"}, {"QualifierName": ["chemically induced", "enzymology", "physiopathology", "prevention & control"], "DescriptorName": "Bronchial Hyperreactivity"}, {"QualifierName": [], "DescriptorName": "Bronchial Provocation Tests"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["metabolism"], "DescriptorName": "Chemokines"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Dicumarol"}, {"QualifierName": ["analogs & derivatives", "metabolism"], "DescriptorName": "Dinoprost"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": ["drug effects", "enzymology"], "DescriptorName": "Epithelial Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-8"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": [], "DescriptorName": "Mice, Knockout"}, {"QualifierName": [], "DescriptorName": "NAD(P)H Dehydrogenase (Quinone)"}, {"QualifierName": ["antagonists & inhibitors", "deficiency", "genetics", "metabolism"], "DescriptorName": "NADPH Dehydrogenase"}, {"QualifierName": ["toxicity"], "DescriptorName": "Oxidants"}, {"QualifierName": [], "DescriptorName": "Oxidation-Reduction"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": ["chemically induced", "enzymology", "physiopathology", "prevention & control"], "DescriptorName": "Pneumonia"}, {"QualifierName": [], "DescriptorName": "Time Factors"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "American Thoracic Society. Health effects of outdoor air pollution. Part 2. Committee of the Environmental and Occupational Health Assembly of the American Thoracic Society. Am J Respir Crit Care Med 1996;153:477\u2013498.", "ArticleIdList": ["8564086"]}, {"Citation": "Peden DB. The epidemiology and genetics of asthma risk associated with air pollution. J Allergy Clin Immunol 2005;115:213\u2013219. (quiz 220).", "ArticleIdList": ["15696070"]}, {"Citation": "Foster W. Effects of oxidants. In: Swift D, Foster W, editors. Air pollutants and the respiratory tract. New York: Marcel Dekker; 1999. pp. 147\u2013179."}, {"Citation": "Trasande L, Thurston GD. The role of air pollution in asthma and other pediatric morbidities. J Allergy Clin Immunol 2005;115:689\u2013699.", "ArticleIdList": ["15805986"]}, {"Citation": "Gent JF, Triche EW, Holford TR, Belanger K, Bracken MB, Beckett WS, Leaderer BP. Association of low-level ozone and fine particles with respiratory symptoms in children with asthma. JAMA 2003;290:1859\u20131867.", "ArticleIdList": ["14532314"]}, {"Citation": "Fanucchi MV, Plopper CG, Evans MJ, Hyde DM, Van Winkle LS, Gershwin LJ, Schelegle ES. Cyclic exposure to ozone alters distal airway development in infant rhesus monkeys. Am J Physiol Lung Cell Mol Physiol 2006;291:L644\u2013L650.", "ArticleIdList": ["16648242"]}, {"Citation": "Pryor WA, Squadrito GL, Friedman M. The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Radic Biol Med 1995;19:935\u2013941.", "ArticleIdList": ["8582671"]}, {"Citation": "Wright DT, Adler KB, Akley NJ, Dailey LA, Friedman M. Ozone stimulates release of platelet activating factor and activates phospholipases in guinea pig tracheal epithelial cells in primary culture. Toxicol Appl Pharmacol 1994;127:27\u201336.", "ArticleIdList": ["8048050"]}, {"Citation": "Kafoury RM, Pryor WA, Squadrito GL, Salgo MG, Zou X, Friedman M. Lipid ozonation products activate phospholipases A2, C, and D. Toxicol Appl Pharmacol 1998;150:338\u2013349.", "ArticleIdList": ["9653065"]}, {"Citation": "Leikauf GD, Zhao Q, Zhou S, Santrock J. Ozonolysis products of membrane fatty acids activate eicosanoid metabolism in human airway epithelial cells. Am J Respir Cell Mol Biol 1993;9:594\u2013602.", "ArticleIdList": ["8257591"]}, {"Citation": "Jaspers I, Flescher E, Chen LC. Ozone-induced IL-8 expression and transcription factor binding in respiratory epithelial cells. Am J Physiol 1997;272:L504\u2013L511.", "ArticleIdList": ["9124608"]}, {"Citation": "Nichols BG, Woods JS, Luchtel DL, Corral J, Koenig JQ. Effects of ozone exposure on nuclear factor-kappaB activation and tumor necrosis factor-alpha expression in human nasal epithelial cells. Toxicol Sci 2001;60:356\u2013362.", "ArticleIdList": ["11248148"]}, {"Citation": "Koren HS, Devlin RB, Graham DE, Mann R, McGee MP, Horstman DH, Kozumbo WJ, Becker S, House DE, McDonnell WF, et al. Ozone-induced inflammation in the lower airways of human subjects. Am Rev Respir Dis 1989;139:407\u2013415.", "ArticleIdList": ["2913889"]}, {"Citation": "Holtzman MJ, Fabbri LM, O'Byrne PM, Gold BD, Aizawa H, Walters EH, Alpert SE, Nadel JA. Importance of airway inflammation for hyperresponsiveness induced by ozone. Am Rev Respir Dis 1983;127:686\u2013690.", "ArticleIdList": ["6859651"]}, {"Citation": "Seltzer J, Bigby BG, Stulbarg M, Holtzman MJ, Nadel JA, Ueki IF, Leikauf GD, Goetzl EJ, Boushey HA. O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J Appl Physiol 1986;60:1321\u20131326.", "ArticleIdList": ["3084448"]}, {"Citation": "Foster W, Brown R, Macri K, Mitchell C. Bronchial reactivity of healthy subjects: 18\u201320 h postexposure to ozone. J Appl Physiol 2000;89:1804\u20131810.", "ArticleIdList": ["11053329"]}, {"Citation": "Hiltermann JT, Lapperre TS, van Bree L, Steerenberg PA, Brahim JJ, Sont JK, Sterk PJ, Hiemstra PS, Stolk J. Ozone-induced inflammation assessed in sputum and bronchial lavage fluid from asthmatics: a new noninvasive tool in epidemiologic studies on air pollution and asthma. Free Radic Biol Med 1999;27:1448\u20131454.", "ArticleIdList": ["10641740"]}, {"Citation": "Bosson J, Stenfors N, Bucht A, Helleday R, Pourazar J, Holgate ST, Kelly FJ, Sandstrom T, Wilson S, Frew AJ, et al. Ozone-induced bronchial epithelial cytokine expression differs between healthy and asthmatic subjects. Clin Exp Allergy 2003;33:777\u2013782.", "ArticleIdList": ["12801312"]}, {"Citation": "Li YF, Gauderman WJ, Avol E, Dubeau L, Gilliland FD. Associations of tumor necrosis factor G-308A with childhood asthma and wheezing. Am J Respir Crit Care Med 2006;173:970\u2013976.", "ArticleIdList": ["PMC2662916", "16456144"]}, {"Citation": "Romieu I, Sienra-Monge JJ, Ramirez-Aguilar M, Moreno-Macias H, Reyes-Ruiz NI, Estela del Rio-Navarro B, Hernandez-Avila M, London SJ. Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City. Thorax 2004;59:8\u201310.", "ArticleIdList": ["PMC1758856", "14694237"]}, {"Citation": "Romieu I, Ramirez-Aguilar M, Sienra-Monge JJ, Moreno-Macias H, del Rio-Navarro BE, David G, Marzec J, Hernandez-Avila M, London S. GSTM1 and GSTP1 and respiratory health in asthmatic children exposed to ozone. Eur Respir J 2006;28:953\u2013959.", "ArticleIdList": ["16870661"]}, {"Citation": "Corrradi M, Alinovi R, Goldoni M, Vettori MV, Folesani G, Mozzoni P, Cavazzini S, Bergamaschi E, Rossi L, Mutti A. Biomarkers of oxidative stress after controlled human exposure to ozone. Toxicol Lett 2002;134:219\u2013225.", "ArticleIdList": ["12191881"]}, {"Citation": "Bergamaschi E, De Palma G, Mozzoni P, Vanni S, Vettori MV, Broeckaert F, Bernard A, Mutti A. Polymorphism of quinone-metabolizing enzymes and susceptibility to ozone-induced acute effects. Am J Respir Crit Care Med 2001;163:1426\u20131431.", "ArticleIdList": ["11371413"]}, {"Citation": "David G, Romieu I, Sienra-Monge JJ, Collins WJ, Ramirez-Auilar M, del Rio-Navarro BE, Reyes-Ruiz NI, Morris RW, Marzec JM, London SJ. Nicotinamide adenine dinucleotide (Phosphate) reduced:quinone oxidoreductase and glutathione s-transferase M1 polymorphisms and childhood asthma. Am J Respir Crit Care Med 2003;168:1199\u20131204.", "ArticleIdList": ["12969868"]}, {"Citation": "Savov JD, Whitehead GS, Wang J, Liao G, Usuka J, Peltz G, Foster WM, Schwartz DA. Ozone-induced acute pulmonary injury in inbred mouse strains. Am J Respir Cell Mol Biol 2004;31:69\u201377.", "ArticleIdList": ["14975936"]}, {"Citation": "Krunkosky TM, Martin LD, Fischer BM, Voynow JA, Adler KB. Effects of TNFalpha on expression of ICAM-1 in human airway epithelial cells in vitro: oxidant-mediated pathways and transcription factors. Free Radic Biol Med 2003;35:1158\u20131167.", "ArticleIdList": ["14572618"]}, {"Citation": "Zheng S, Byrd AS, Fischer BM, Grover AR, Ghio AJ, Voynow JA. Regulation of MUC5AC expression by NAD(P)H:quinone oxidoreductase 1. Free Radic Biol Med 2007;42:1398\u20131408.", "ArticleIdList": ["PMC1913945", "17395013"]}, {"Citation": "Voynow JA, Fischer BM, Malarkey DE, Burch LH, Wong T, Longphre M, Ho SB, Foster WM. Neutrophil elastase induces mucus cell metaplasia in mouse lung. Am J Physiol Lung Cell Mol Physiol 2004;287:L1293\u2013L1302.", "ArticleIdList": ["15273079"]}, {"Citation": "Ernster LDT. Diaphorase. Methods Enzymol 1967;10:309\u2013317."}, {"Citation": "Snedecor GW, Cochran WG. Statistical methods. Ames: Iowa State University Press; 1980."}, {"Citation": "Ghio AJ, Turi JL, Madden MC, Dailey LA, Richards JD, Stonehuerner JG, Morgan DL, Singleton S, Garrick LM, Garrick MD. Lung injury after ozone exposure is iron dependent. Am J Physiol Lung Cell Mol Physiol 2007;292:L134\u2013L143.", "ArticleIdList": ["16905637"]}, {"Citation": "Siegel D, Franklin WA, Ross D. Immunohistochemical detection of NADPH:Quinone oxidoreductase in human lung and lung tumors. Clin Cancer Res 1998;4:2065\u20132070.", "ArticleIdList": ["9748120"]}, {"Citation": "Navarro F, Arroyo A, Martin SF, Bello RI, de Cabo R, Burgess JR, Navas P, Villalba JM. Protective role of ubiquinone in vitamin E and selenium-deficient plasma membranes. Biofactors 1999;9:163\u2013170.", "ArticleIdList": ["10416028"]}, {"Citation": "Navarro F, Navas P, Burgess JR, Bello RI, De Cabo R, Arroyo A, Villalba JM. Vitamin E and selenium deficiency induces expression of the ubiquinone-dependent antioxidant system at the plasma membrane. FASEB J 1998;12:1665\u20131673.", "ArticleIdList": ["9837856"]}, {"Citation": "Ross D, Kepa JK, Winski SL, Beall HD, Anwar A, Siegel D. NADPH:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem Biol Interact 2000;129:77\u201397.", "ArticleIdList": ["11154736"]}, {"Citation": "Ross D, Siegel D. NADPH:Quinone Oxidoreductase 1 (NQO1, Dt-Diaphorase), functions and pharmacogenetics. Methods Enzymol 2004;382:115\u2013145.", "ArticleIdList": ["15047100"]}, {"Citation": "Cadenas E. Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism. Biochem Pharmacol 1995;49:127\u2013140.", "ArticleIdList": ["7530954"]}, {"Citation": "Watanabe N, Forman HJ. Autooxidation of extracellular hydroquinones is a causative event for the cytotoxicity of menadione and DMNQ in A549-S cells. Arch Biochem Biophys 2003;411:145\u2013157.", "ArticleIdList": ["PMC2795776", "12590933"]}, {"Citation": "Brar S, Kennedy TP, Whorton AR, Sturrock AB, Huecksteadt TP, Ghio AJ, Hoidal JR. Reactive oxygen species from NAD(P)H: quinone oxidoreductase constitutively activate NF-kB in malignant melanoma cells. Am J Physiol Cell Physiol 2001;280:C659\u2013C676.", "ArticleIdList": ["11171586"]}, {"Citation": "Bey EA, Bentle MS, Reinicke KE, Dong Y, Yang CR, Girard L, Minna JD, Bornmann WG, Gao J, Boothman DA. An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone. Proc Natl Acad Sci USA 2007;104:11832\u201311837.", "ArticleIdList": ["PMC1913860", "17609380"]}, {"Citation": "Wondrak GT. NQO1-activated phenothiazinium redox cyclers for the targeted bioreductive induction of cancer cell apoptosis. Free Radic Biol Med 2007;43:178\u2013190.", "ArticleIdList": ["PMC2705808", "17603928"]}, {"Citation": "Winski SL, Swann E, Hargreaves RH, Dehn DL, Butler J, Moody CJ, Ross D. Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones. Biochem Pharmacol 2001;61:1509\u20131516.", "ArticleIdList": ["11377380"]}, {"Citation": "Morrow JD, Roberts LJ. The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am J Respir Crit Care Med 2002;166:S25\u2013S30.", "ArticleIdList": ["12471085"]}, {"Citation": "Janssen LJ, Catalli A, Helli P. The pulmonary biology of isoprostanes. Antioxid Redox Signal 2005;7:244\u2013255.", "ArticleIdList": ["15650412"]}, {"Citation": "Janssen LJ. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 2001;280:L1067\u2013L1082.", "ArticleIdList": ["11350785"]}, {"Citation": "Okazawa A, Kawikova I, Cui ZH, Skoogh BE, Lotvall J. 8-Epi-PGF2alpha induces airflow obstruction and airway plasma exudation in vivo. Am J Respir Crit Care Med 1997;155:436\u2013441.", "ArticleIdList": ["9032175"]}, {"Citation": "Vacchiano CA, Tempel GE. Role of nonenzymatically generated prostanoid, 8-iso-PGF2 alpha, in pulmonary oxygen toxicity. J Appl Physiol 1994;77:2912\u20132917.", "ArticleIdList": ["7896640"]}, {"Citation": "Banerjee M, Kang KH, Morrow JD, Roberts LJ, Newman JH. Effects of a novel prostaglandin, 8-epi-PGF2 alpha, in rabbit lung in situ. Am J Physiol 1992;263:H660\u2013H663.", "ArticleIdList": ["1415588"]}, {"Citation": "Janssen LJ, Premji M, Netherton S, Coruzzi J, Lu-Chao H, Cox PG. Vasoconstrictor actions of isoprostanes via tyrosine kinase and Rho kinase in human and canine pulmonary vascular smooth muscles. Br J Pharmacol 2001;132:127\u2013134.", "ArticleIdList": ["PMC1572542", "11156569"]}, {"Citation": "Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease: Oxidative Stress Study Group. Am J Respir Crit Care Med 1997;156:341\u2013357.", "ArticleIdList": ["9279209"]}, {"Citation": "Hazbun ME, Hamilton R, Holian A, Eschenbacher WL. Ozone-induced increases in substance P and 8-epi-prostaglandin F2 alpha in the airways of human subjects. Am J Respir Cell Mol Biol 1993;9:568\u2013572.", "ArticleIdList": ["7692898"]}, {"Citation": "Samet JM, Hatch GE, Horstman D, Steck-Scott S, Arab L, Bromberg PA, Levine M, McDonnell WF, Devlin RB. Effect of antioxidant supplementation on ozone-induced lung injury in human subjects. Am J Respir Crit Care Med 2001;164:819\u2013825.", "ArticleIdList": ["11549539"]}]}], "History": [{"Year": "2008", "Month": "12", "Day": "9", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "6", "Day": "26", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "12", "Day": "9", "Hour": "9", "Minute": "0"}, {"Year": "2010", "Month": "7", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["19059883", "PMC2701957", "10.1165/rcmb.2008-0381OC", "2008-0381OC"]}}], "PubmedBookArticle": []}